Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Lung Cancer (Amsterdam, Netherlands)|February 12, 2022
A systematic review and meta-analysis of the adequacy of endobronchial ultrasound transbronchial needle aspiration for next-generation sequencing in patients with non-small cell lung cancerJoseph J Zhao, Hiang Ping Chan, Yu Yang Soon, et al.
Thoracic Cancer|July 1, 2026
An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Common EGFR Mutations Treated With AfatinibKenneth Sooi, Pongwut Danchaivijtr, C K Wong, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2026
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerabilityGerrina Ruiter, Xiuning Le, Ross A Soo, et al.
Asia-Pacific Journal of Clinical Oncology|May 3, 2017
Management of epidermal growth factor receptor tyrosine kinase inhibitor-related cutaneous and gastrointestinal toxicitiesDerrick Chen-Wee Aw, Eng Huat Tan, Tan Min Chin, et al.
Oncotarget|June 7, 2018
Prognostic significance of immune cells in non-small cell lung cancer: meta-analysisRoss A Soo, Zhaojin Chen, Rebecca Siew Yan Teng, et al.
Thoracic Cancer|May 1, 2011
How many adenocarcinoma lung cancers come from bronchioloalveolar carcinoma?Alvin S Wong, Kar-Yin Seto, Bertrand Ang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 3, 2024
Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunitiesJii Bum Lee, Yiqing Huang, Yuko Oya, et al.
JTO Clinical and Research Reports|October 3, 2025
What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?Sun Min Lim, Joo Sung Gabriel Shim, Hyo Sup Shim, et al.
Drugs - Real World Outcomes|September 12, 2021
Treatment Patterns in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: Analysis of US Insurance Claims DatabasesRoss A Soo, Takashi Seto, Jhanelle E Gray, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directionsRoss A Soo, Sun Min Lim, Nicholas L Syn, et al.
Pageof 16